Source:http://linkedlifedata.com/resource/pubmed/id/20513011
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2010-5-31
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1527-3350
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
51
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2227-8; author reply 2228
|
| pubmed:meshHeading |
pubmed-meshheading:20513011-Animals,
pubmed-meshheading:20513011-Anticonvulsants,
pubmed-meshheading:20513011-Drug-Induced Liver Injury,
pubmed-meshheading:20513011-Hepatic Stellate Cells,
pubmed-meshheading:20513011-Humans,
pubmed-meshheading:20513011-Liver Cirrhosis,
pubmed-meshheading:20513011-Valproic Acid
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
|
| pubmed:publicationType |
Letter,
Comment
|